Zobrazeno 1 - 10
of 106
pro vyhledávání: '"D, Türck"'
Publikováno v:
European Journal of Clinical Pharmacology. 51:421-425
The effect of multiple oral doses of meloxicam 15 mg on the pharmacodynamics and pharmacokinetics of warfarin was investigated in healthy male volunteers. Warfarin was administered in an individualized dose to achieve a stable reduction in prothrombi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab47886376e6bfd2369fff96e355a94
https://doi.org/10.1007/s002280050224
https://doi.org/10.1007/s002280050224
Publikováno v:
Scopus-Elsevier
Aims The aim of the present study was to determine how the pharmacokinetics of meloxicam are affected by kidney dysfunction and consequently to define the appropriate dose for the use of meloxicam in patients with mild or moderate renal impairment. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2a747b3aef22b5d715d3c9920c9df4
https://doi.org/10.1111/j.1365-2125.1997.tb00030.x
https://doi.org/10.1111/j.1365-2125.1997.tb00030.x
Publikováno v:
Rheumatology. 35:13-16
Meloxicam is a new preferential cyclooxygenase-2 (COX-2) inhibitor currently for the treatment of osteoarthritis and rheumatoid arthritis. Its pharmacokinetic profile is characterized by a prolonged and almost complete absorption and the drug is > 99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03ffa42bc3a537eea55187a54e85fd60
https://doi.org/10.1093/rheumatology/35.suppl_1.13
https://doi.org/10.1093/rheumatology/35.suppl_1.13
Publikováno v:
Scopus-Elsevier
The pharmacokinetics of meloxicam were investigated in 12 patients with clinically stable liver cirrhosis after a single oral dose of 15mg. 12 healthy volunteers received the same regimen in earlier studies and the results of both groups were compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb06e8bf52470128e3a7ade1b1472fb9
https://doi.org/10.2165/00044011-199611020-00005
https://doi.org/10.2165/00044011-199611020-00005
Publikováno v:
ResearcherID
This paper reviews recent studies that have aimed to establish the relative bioavailability of a new oral formulation of meloxicam, and to evaluate its safety and efficacy in a clinical setting. For the bioavailability study, 16 healthy volunteers we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44205b72b579d1d05dfaa2b9213bccf8
https://doi.org/10.1007/pl00000219
https://doi.org/10.1007/pl00000219
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 50
This paper reviews published studies on the intramuscular use of meloxicam in acute rheumatic conditions. Data were obtained from 68 healthy volunteers and >800 patients with conditions such as arthritis, sciatica and lumbago who were treated with in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd58b2c97716417158a81c259000f3e
https://pubmed.ncbi.nlm.nih.gov/11339521
https://pubmed.ncbi.nlm.nih.gov/11339521
Autor:
J, Stangier, J, Schmid, D, Türck, H, Switek, A, Verhagen, P A, Peeters, S P, van Marle, W J, Tamminga, F A, Sollie, J H, Jonkman
Publikováno v:
Journal of clinical pharmacology. 40(12 Pt 1)
The study was conducted in healthy male volunteers to evaluate the absorption, metabolic pattern, and mode of elimination of telmisartan, a nonpeptide angiotensin II receptor antagonist. [14C]telmisartan was administered orally in solution as a singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9904109452f533c762dc4495757e6e01
https://pubmed.ncbi.nlm.nih.gov/11185629
https://pubmed.ncbi.nlm.nih.gov/11185629
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michel Pairet, J. Van Ryn, Willi Dr Diederen, Guenther Dr Engelhardt, Hans Schierok, D. Türck, Annerose Mauz
Publikováno v:
Selective COX-2 Inhibitors ISBN: 9789401060417
Since the discovery of a second isoenzyme of cyclooxygenase (COX), COX-21,2, it has been hypothesized that the anti-inflammatory effects of non-steroid anti-inflammatory drugs (NSAIDs) are achieved through a mechanism different from that underlying t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9cf5587109b2a6d1bb96fbb980e9508
https://doi.org/10.1007/978-94-011-4872-6_3
https://doi.org/10.1007/978-94-011-4872-6_3
